Creekmur Asset Management LLC Has $1.01 Million Stock Position in DaVita Inc. (NYSE:DVA)

Creekmur Asset Management LLC cut its stake in shares of DaVita Inc. (NYSE:DVA) by 24.1% in the fourth quarter, Holdings Channel reports. The firm owned 6,720 shares of the company’s stock after selling 2,132 shares during the quarter. Creekmur Asset Management LLC’s holdings in DaVita were worth $1,005,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the stock. SBI Securities Co. Ltd. acquired a new stake in shares of DaVita in the 4th quarter valued at approximately $41,000. Quarry LP acquired a new stake in DaVita during the 3rd quarter worth $60,000. Venturi Wealth Management LLC grew its stake in DaVita by 59.8% in the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock valued at $61,000 after acquiring an additional 152 shares during the period. Versant Capital Management Inc raised its position in shares of DaVita by 58.7% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $68,000 after purchasing an additional 169 shares during the period. Finally, Blue Trust Inc. boosted its holdings in shares of DaVita by 39.7% in the fourth quarter. Blue Trust Inc. now owns 461 shares of the company’s stock valued at $76,000 after buying an additional 131 shares during the period. Institutional investors and hedge funds own 90.12% of the company’s stock.

DaVita Stock Down 0.7 %

Shares of DVA opened at $151.82 on Wednesday. DaVita Inc. has a 52 week low of $125.64 and a 52 week high of $179.60. The firm has a market cap of $12.15 billion, a P/E ratio of 14.14, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99. The firm’s 50-day simple moving average is $156.77 and its 200 day simple moving average is $157.44. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26.

DaVita (NYSE:DVA) last announced its earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. On average, analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on DVA shares. StockNews.com downgraded DaVita from a “buy” rating to a “hold” rating in a report on Wednesday. Barclays increased their target price on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 target price on DaVita in a research report on Friday, February 21st. Finally, Cowen reiterated a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, DaVita currently has an average rating of “Hold” and an average target price of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.